Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

May 31, 2017May 31, 2017

New Study to Assess ADXS-DUAL, Opdivo Immunotherapy Combo in Metastatic Cervical Cancer

News

Advaxis and Bristol-Myers Squibb have entered a clinical collaboration to evaluate the second generation of axalimogene filolisbac, called ADXS-DUAL, in combination with Opdivo (nivolumab) in women with metastatic cervical cancer. ... Read more

April 26, 2017

Inovio Starts Phase 2 Trial of VGX-3100 Vaccine for Pre-cancerous Vulvar Lesions

News

Inovio’s Phase 2 trial assessing the effectiveness of VGX-3100 in patients with pre-cancerous lesions of the vulva, or vulvar intraepithelial neoplasia (VIN), has began dosing patients. VGX-3100, a human papilloma virus ... Read more

April 24, 2017

Agenus Begins Clinical Trial Testing New Therapy for Cervical Cancer, Solid Tumors

News

The first patient has been dosed in the Phase 1/2 trial testing AGEN2034, Agenus‘ new PD-1 inhibitor, in patients with advanced solid tumors and cervical cancer. The trial is currently ... Read more

April 3, 2017April 3, 2017

Cue Biopharma Develops Its First Immunotherapy for Cervical Cancer

News

Cue Biopharma has developed its first immunotherapy against cervical and other cancers driven by the human papillomavirus (HPV). It is already preparing an application for investigational new drug status for Cue-101, ... Read more

March 17, 2017March 17, 2017

Advaxis Vaccine Generates Unprecedented Survival Rates in Metastatic Cervical Cancer

News

Advaxis‘ cancer vaccine, axalimogene filolisbac, significantly increased cervical cancer patients’ 12-month survival rate, according to a clinical trial. Patients with persistent or recurrent metastatic carcinoma of the cervix (PRmCC) who took the ... Read more

March 3, 2017

Report Urges Cytology Screening as Smart Way to Slash Cervical Cancer Rates in Poor Countries

News

In relatively poor countries where a lack of infrastructure prevents widespread implementation of effective screening programs, collecting a small sample of cells only from women at high risk of cervical cancer ... Read more

February 24, 2017

Current, Former Female Inmates Far More Likely to Develop Cervical, Lung Cancer, Study Finds

News

Women who have done time in prison are three times more likely to die from cervical cancer than women who were never behind bars, according to a Canadian study. That’s one of ... Read more

February 21, 2017

Lesbians Less Likely to Be Screened for Cervical Cancer than Other Women

News

Lesbians are less likely to get timely cervical cancer screening than heterosexual and bisexual women, concludes a study by Rice University. The study, “Cancer Screening Utilization Among U.S. Women: How Mammogram ... Read more

February 15, 2017April 24, 2017

Inovio, ApolloBio to Jointly Develop HPV Vaccine in China, Taiwan

News

ApolloBio now enjoys exclusive rights to market Inovio Pharmaceuticals‘ DNA immunotherapy product, VGX-3100, in China and Taiwan under a new collaboration and licensing agreement. The deal allows ApolloBio to develop VGX-3100 as a non-surgical treatment ... Read more

February 13, 2017

HPV Vaccination in 2-Dose Schedule Endorsed by American Cancer Society

News

In October 2016, the U.S. Food and Drug Administration (FDA) approved the two-dose schedule for the human papillomavirus (HPV) vaccine, which was later recommended for boys and girls ages 9 ... Read more